Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: The TICAP Prospective Phase 1 Controlled Trial

Circulation Research

Volumn 116, Issue 4, 2015, Pages 653-664

  Ishigami, Shuta ^a   Ohtsuki, Shinichi ^a   Tarui, Suguru ^a   Ousaka, Daiki ^a   Eitoku, Takahiro ^a   Kondo, Maiko ^a   Okuyama, Michihiro ^a   Kobayashi, Junko ^a   Baba, Kenji ^a   Arai, Sadahiko ^a   Kawabata, Takuya ^a   Yoshizumi, Ko ^a   Tateishi, Atsushi ^a   Kuroko, Yosuke ^a   Iwasaki, Tatsuo ^a   Sato, Shuhei ^a   Kasahara, Shingo ^a   Sano, Shunji ^a   Oh, Hidemasa ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cell therapy; Congenital heart disease; Hypoplastic left heart syndrome; Stem cells

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ANGIOGRAPHY; ARTICLE; AUTOLOGOUS CARDIOSPHERE DERIVED CELL; BALLOON DILATATION; BODY GROWTH; CARDIAC STEM CELL; CARDIOVASCULAR MAGNETIC RESONANCE; CELL TRANSFER; CHILD; COIL EMBOLIZATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SINGLE VENTRICLE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; ST SEGMENT ELEVATION; ADVERSE EFFECTS; AUTOTRANSPLANTATION; CLINICAL TRIAL; COMPLICATION; CONTROLLED CLINICAL TRIAL; CONVALESCENCE; DOPPLER ECHOCARDIOGRAPHY; FEASIBILITY STUDY; HEART MUSCLE CELL; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; INFANT; JAPAN; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; STEM CELL TRANSPLANTATION; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, DOPPLER; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; INFANT, NEWBORN; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MYOCYTES, CARDIAC; PALLIATIVE CARE; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; STROKE VOLUME; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, RIGHT;

EID: 84924165716     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.304671     Document Type: Article

References (44)

1. Barron DJ, Kilby MD, Davies B, Wright JG, Jones TJ, Brawn WJ. Hypoplastic left heart syndrome. Lancet. 2009;374:551-564. doi: 10.1016/S0140-6736(09)60563-8.
2. Lamour JM, Kanter KR, Naftel DC, Chrisant MR, Morrow WR, Clemson BS, Kirklin JK; Cardiac Transplant Registry Database; Pediatric Heart Transplant Study. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol. 2009;54:160-165. doi: 10.1016/j.jacc.2009.04.020.
3. Sano S, Ishino K, Kawada M, Arai S, Kasahara S, Asai T, Masuda Z, Takeuchi M, Ohtsuki S. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2003;126:504-509; discussion 509.
4. Altmann K, Printz BF, Solowiejczky DE, Gersony WM, Quaegebeur J, Apfel HD. Two-dimensional echocardiographic assessment of right ventricular function as a predictor of outcome in hypoplastic left heart syndrome. Am J Cardiol. 2000;86:964-968.
5. Hsu DT, Pearson GD. Heart failure in children: part I: history, etiology, and pathophysiology. Circ Heart Fail. 2009;2:63-70. doi: 10.1161/CIRCHEARTFAILURE.108.820217.
6. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisén J. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98-102. doi: 10.1126/science.1164680.
7. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331:1078-1080. doi: 10.1126/science.1200708.
8. Beohar N, Rapp J, Pandya S, Losordo DW. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol. 2010;56:1287-1297. doi: 10.1016/j.jacc.2010.05.039.
9. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358:1370-1380. doi: 10.1056/NEJMra072139.
10. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003;100:12313-12318. doi: 10.1073/pnas.2132126100.
11. Tateishi K, Ashihara E, Honsho S, Takehara N, Nomura T, Takahashi T, Ueyama T, Yamagishi M, Yaku H, Matsubara H, Oh H. Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. Biochem Biophys Res Commun. 2007;352:635-641. doi: 10.1016/j.bbrc.2006.11.096.
12. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, Giacomello A, Abraham MR, Marbán E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115:896-908. doi: 10.1161/CIRCULATIONAHA.106.655209.
13. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379:895-904. doi: 10.1016/S0140-6736(12)60195-0.
14. Ptaszek LM, Mansour M, Ruskin JN, Chien KR. Towards regenerative therapy for cardiac disease. Lancet. 2012;379:933-942. doi: 10.1016/S0140-6736(12)60075-0.
15. Zeisberg EM, Kalluri R. Origins of cardiac fibroblasts. Circ Res. 2010;107:1304-1312. doi: 10.1161/CIRCRESAHA.110.231910.
16. Dubois NC, Craft AM, Sharma P, Elliott DA, Stanley EG, Elefanty AG, Gramolini A, Keller G. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol. 2011;29:1011-1018. doi: 10.1038/nbt.2005.
17. Takehara N, Tsutsumi Y, Tateishi K, Ogata T, Tanaka H, Ueyama T, Takahashi T, Takamatsu T, Fukushima M, Komeda M, Yamagishi M, Yaku H, Tabata Y, Matsubara H, Oh H. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol. 2008;52:1858-1865. doi: 10.1016/j.jacc.2008.06.052.
18. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210-1221. doi: 10.1056/NEJMoa060186.
19. Helbing WA, Bosch HG, Maliepaard C, Rebergen SA, van der Geest RJ, Hansen B, Ottenkamp J, Reiber JH, de Roos A. Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children. Am J Cardiol. 1995;76:589-594.
20. Zilberman MV, Khoury PR, Kimball RT. Two-dimensional echocardiographic valve measurements in healthy children: gender-specific differences. Pediatr Cardiol. 2005;26:356-360. doi: 10.1007/s00246-004-0736-z.
21. Fogel MA, Pawlowski TW, Whitehead KK, Harris MA, Keller MS, Glatz AC, Zhu W, Shore D, Diaz LK, Rome JJ. Cardiac magnetic resonance and the need for routine cardiac catheterization in single ventricle patients prior to Fontan: a comparison of 3 groups: pre-Fontan CMR versus cath evaluation. J Am Coll Cardiol. 2012;60:1094-1102. doi: 10.1016/j.jacc.2012.06.021.
22. Tanoue Y, Sese A, Ueno Y, Joh K, Hijii T. Bidirectional Glenn procedure improves the mechanical efficiency of a total cavopulmonary connection in high-risk fontan candidates. Circulation. 2001;103:2176-2180.
23. Dillman JR, Dorfman AL, Attili AK, Agarwal PP, Bell A, Mueller GC, Hernandez RJ. Cardiovascular magnetic resonance imaging of hypoplastic left heart syndrome in children. Pediatr Radiol. 2010;40:261-74; quiz 379. doi: 10.1007/s00247-009-1473-5.
24. Loscalzo J. Pilot trials in clinical research: of what value are they? Circulation. 2009;119:1694-1696. doi: 10.1161/CIRCULATIONAHA.109.861625.
25. Hare JM, Bolli R, Cooke JP, et al Cardiovascular Cell Therapy Research Network. Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Circulation. 2013;127:1630-1635. doi: 10.1161/CIRCULATIONAHA.112.000779.
26. Moyé LA, Tita AT. Defending the rationale for the two-tailed test in clinical research. Circulation. 2002;105:3062-3065.
27. Cabral HJ. Multiple comparisons procedures. Circulation. 2008;117:698-701. doi: 10.1161/CIRCULATIONAHA.107.700971.
28. Kusuoka H, Hoffman JI. Advice on statistical analysis for Circulation Research. Circ Res. 2002;91:662-671.
29. Eerola A, Poutanen T, Savukoski T, Pettersson K, Sairanen H, Jokinen E, Pihkala J. Cardiac troponin I, cardiac troponin-specific autoantibodies and natriuretic peptides in children with hypoplastic left heart syndrome. Interact Cardiovasc Thorac Surg. 2014;18:80-85. doi: 10.1093/icvts/ivt430.
30. Rogers LS, Glatz AC, Ravishankar C, Spray TL, Nicolson SC, Rychik J, Rush CH, Gaynor JW, Goldberg DJ. 18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol. 2012;60:1018-1025. doi: 10.1016/j.jacc.2012.05.010.
31. Tateishi K, Takehara N, Matsubara H, Oh H. Stemming heart failure with cardiac- or reprogrammed-stem cells. J Cell Mol Med. 2008;12:2217-2232. doi: 10.1111/j.1582-4934.2008.00487.x.
32. Bernstein HS, Srivastava D. Stem cell therapy for cardiac disease. Pediatr Res. 2012;71:491-499. doi: 10.1038/pr.2011.61.
33. Rupp S, Zeiher AM, Dimmeler S, Tonn T, Bauer J, Jux C, Akintuerk H, Schranz D. A regenerative strategy for heart failure in hypoplastic left heart syndrome: intracoronary administration of autologous bone marrow-derived progenitor cells. J Heart Lung Transplant. 2010;29:574-577. doi: 10.1016/j.healun.2009.10.006.
34. Rupp S, Jux C, Bönig H, Bauer J, Tonn T, Seifried E, Dimmeler S, Zeiher AM, Schranz D. Intracoronary bone marrow cell application for terminal heart failure in children. Cardiol Young. 2012;22:558-563. doi: 10.1017/S1047951112000066.
35. Lee ST, White AJ, Matsushita S, Malliaras K, Steenbergen C, Zhang Y, Li TS, Terrovitis J, Yee K, Simsir S, Makkar R, Marbán E. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol. 2011;57:455-465. doi: 10.1016/j.jacc.2010.07.049.
36. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marbán L, Marbán E. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol. 2012;59:942-953. doi: 10.1016/j.jacc.2011.11.029.
37. Frommelt PC, Guey LT, Minich LL, et al Pediatric Heart Network Investigators. Does initial shunt type for the Norwood procedure affect echocardiographic measures of cardiac size and function during infancy?: the Single Vventricle Reconstruction trial. Circulation. 2012;125:2630-2638. doi: 10.1161/CIRCULATIONAHA.111.072694.
38. Rathod RH, Prakash A, Powell AJ, Geva T. Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am Coll Cardiol. 2010;55:1721-1728. doi: 10.1016/j.jacc.2009.12.036.
39. Simpson DL, Mishra R, Sharma S, Goh SK, Deshmukh S, Kaushal S. A strong regenerative ability of cardiac stem cells derived from neonatal hearts. Circulation. 2012;126:S46-S53. doi: 10.1161/CIRCULATIONAHA.111.084699.
40. de Jong R, Houtgraaf JH, Samiei S, Boersma E, Duckers HJ. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ Cardiovasc Interv. 2014;7:156-167. doi: 10.1161/CIRCINTERVENTIONS.113.001009.
41. Anderson PA, Sleeper LA, Mahony L, et al Pediatric Heart Network Investigators. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008;52:85-98. doi: 10.1016/j.jacc.2008.01.074.
42. Newburger JW, Sleeper LA, Frommelt PC, et al Pediatric Heart Network Investigators. Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation. 2014;129:2013-2020. doi: 10.1161/CIRCULATIONAHA.113.006191.
43. Bellsham-Revell HR, Tibby SM, Bell AJ, Witter T, Simpson J, Beerbaum P, Anderson D, Austin CB, Greil GF, Razavi R. Serial magnetic resonance imaging in hypoplastic left heart syndrome gives valuable insight into ventricular and vascular adaptation. J Am Coll Cardiol. 2013;61:561-570. doi: 10.1016/j.jacc.2012.11.016.
44. McCrindle BW, Zak V, Sleeper LA, Paridon SM, Colan SD, Geva T, Mahony L, Li JS, Breitbart RE, Margossian R, Williams RV, Gersony WM, Atz AM; Pediatric Heart Network Investigators. Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure. Circulation. 2010;121:34-42. doi: 10.1161/CIRCULATIONAHA.109.869396.